Cell Wall Thickening Is a Common Feature of Vancomycin Resistance in Staphylococcus aureus
Top Cited Papers
- 1 January 2003
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 41 (1) , 5-14
- https://doi.org/10.1128/jcm.41.1.5-14.2003
Abstract
We have previously shown that a thickened cell wall is responsible for the vancomycin resistance of vancomycin-resistant Staphylococcus aureus (VRSA) (equivalent to vancomycin-intermediate S. aureus and glycopeptide-intermediate S. aureus ) strain Mu50 (L. Cui, H. Murakami, K. Kuwahara-Arai, H. Hanaki, and K. Hiramatsu, Antimicrob. Agents Chemother. 44:2276-2285, 2000). However, the mechanism of vancomycin resistance in other VRSA strains remained unclear. In this study, 16 clinical VRSA strains from seven countries were subjected to serial daily passage in drug-free medium. After 10 to 84 days of passage in the nonselective medium, passage-derived strains with decreased MICs of vancomycin (MIC, −6 to 1.64 × 10 −3 . The data indicated that vancomycin-resistant cells are frequently generated from the passage-derived strains even after vancomycin selective pressure is lifted. Cell wall thicknesses and MICs of glycopeptides (vancomycin and teicoplanin) and beta-lactams (imipenem and oxacillin) were determined for a total of 48 strains, including 15 sets of three strains: the clinical VRSA strain, the passage-derived strain, and the vancomycin-resistant mutant strain obtained from the passage-derived strain. No simple correlation between glycopeptide and beta-lactam MICs was seen, while significant correlations between MICs of vancomycin and teicoplanin ( r = 0.679; P < 0.001) and between MICs of imipenem and oxacillin ( r = 0.787; P < 0.001) were recognized. Moreover, all of the VRSA strains had significantly thickened cell walls, which became thinner with the loss of vancomycin resistance during drug-free passages and again became thick in the resistant mutant strains. The data showed that cell wall thickness had high correlation with the MICs of the two glycopeptides (correlation coefficients, 0.908 for vancomycin and 0.655 for teicoplanin) but not with those of the beta-lactam antibiotics tested. These results together with coupled changes of cell wall thickness and vancomycin MICs in 16 isogenic sets of strains indicate that thickening of the cell wall is a common phenotype of clinical VRSA strains and may be a phenotypic determinant for vancomycin resistance in S. aureus.Keywords
This publication has 37 references indexed in Scilit:
- Conversion of Oxacillin-Resistant Staphylococci from Heterotypic to Homotypic Resistance ExpressionAntimicrobial Agents and Chemotherapy, 2002
- Vancomycin-Intermediate Staphylococcus aureus in a Home Health-Care PatientEmerging Infectious Diseases, 2001
- Isolation in Brazil of NosocomialStaphylococcus aureusWith Reduced Susceptibility to VancomycinInfection Control & Hospital Epidemiology, 2001
- Combination Effect of Vancomycin and β-Lactams against a Staphylococcus aureus Strain, Mu3, with Heterogeneous Resistance to VancomycinAntimicrobial Agents and Chemotherapy, 2001
- Increasing Resistance to Vancomycin and Other Glycopeptides in Staphylococcus aureusEmerging Infectious Diseases, 2001
- A Spectrum of Changes Occurs in Peptidoglycan Composition of Glycopeptide-Intermediate Clinical Staphylococcus aureus IsolatesAntimicrobial Agents and Chemotherapy, 2001
- Vancomycin-Intermediate and -Resistant Staphylococcus aureus: What the Infectious Disease Specialist Needs to KnowClinical Infectious Diseases, 2001
- Vancomycin-intermediate Staphylococcus aureus at a Scottish HospitalJournal of Infection, 2000
- Deconstructing VancomycinScience, 1999
- Emergence of Vancomycin Resistance inStaphylococcus aureusNew England Journal of Medicine, 1999